Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Division of Life Sciences and Medicine, University of Science and Technology of China

5 abstracts

Abstract
Adjuvant donafenib for patients with hepatocellular carcinoma at high risk of recurrence following radical resection: A multi-center, retrospective study in China.
Org: No.2 People’s Hospital of Fuyang City, Division of Life Sciences and Medicine, University of Science and Technology of China,
Abstract
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial.
Org: Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China, Tongji Medical College Huazhong University of Science and Technology, Huazhong University of Science and Technology Union Shenzhen Hospital, Wuhan, China, Women's Hospital School of Medicine Zhejiang University,
Abstract
Risk factors for lymph node metastasis and clinical outcomes in cervical cancer patients following primary radical hysterectomy: A single-center analysis of 1495 patients.
Org: Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China, The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China, Division of Life Sciences and Medicine, University of Science and Technology of China, University of Science and Technology of China, Hefei, Anhui, China,
Abstract
Clinical safety and efficacy observation of ex vivo-expanded peripheral blood-derived allogeneic NK cells in the treatment of refractory or recurrent ovarian cancer.
Org: The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China, Division of Life Sciences and Medicine, University of Science and Technology of China, Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Shanghai NK CellTech Co. Ltd,
Abstract
Clinical-grade natural killer cells expanded from donor peripheral blood and anti-leukemia effect against myeloid leukemia.
Org: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China,